GlassScriptPhysician profile
Joseph S Cody
NPI 1376658039
$12,533.80
in general payments reported to CMS, 2019-2025
42 companies · $2,101 in 2025
The $2,101 reported for 2025 was more than what 80% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,117 · 2020: $1,477 · 2021: $1,647 · 2022: $2,150 · 2023: $2,135 · 2024: $1,907 · 2025: $2,101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,594 · Travel and Lodging: $358 · Education: $191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,593.59 |
| Travel and Lodging | $358.07 |
| Education | $190.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,342.59 | 2019-2025 | Skyrizi, Linzess, Viberzi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,514.45 | 2019-2025 | Xifaxan, Trulance |
| Janssen Biotech, INC. | $1,169.04 | 2019-2025 | Stelara, Simponi Aria, Simponi |
| Takeda Pharmaceuticals U.S.A., INC. | $849.74 | 2019-2025 | Entyvio |
| Boston Scientific Corporation | $782.60 | 2019-2025 | Overstitch Endoscopic Suturing System, Resolution 360 Ultra Clip, Apollo Esg Nxt System |
| Genzyme Corporation | $586.24 | 2022-2025 | |
| Redhill Biopharma INC. | $578.27 | 2020-2023 | Talicia, Aemcolo, Movantik |
| Gilead Sciences, INC. | $562.57 | 2019-2025 | |
| Celgene Corporation | $470.89 | 2021-2024 | Zeposia |
| Pfizer INC. | $397.56 | 2019-2025 | |
| Lilly USA, LLC | $207.63 | 2024-2025 | Omvoh |
| Intercept Pharmaceuticals, INC. | $163.66 | 2021-2025 | |
| Fujifilm Healthcare Americas Corporation | $146.96 | 2025 | |
| Zyla Life Sciences, INC. | $138.52 | 2020 | |
| Ironwood Pharmaceuticals, INC | $136.91 | 2019-2020 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vivus LLC | $115.42 | 2019-2025 | Qsymia, Pancreaze |
| Evoke Pharma, INC. | $115.27 | 2021-2023 | Gimoti |
| Madrigal Pharmaceuticals | $107.84 | 2024-2025 | Rezdiffra, Resmetirom |
| Braintree Laboratories, INC. | $104.41 | 2020-2024 | Sutab, Suflave |
| Qol Medical, LLC | $98.10 | 2022 | |
| Nestle Healthcare Nutrition INC. | $97.25 | 2020-2023 | |
| Phathom Pharmaceuticals, INC. | $87.56 | 2023-2025 | Voquezna |
| Ardelyx, INC. | $82.02 | 2023-2024 | Ibsrela |
| Regeneron Healthcare Solutions, INC. | $76.75 | 2023 | Dupixent |
| Intra-Sana Laboratories | $69.59 | 2021-2022 | |
| Celltrion USA INC. | $66.75 | 2024 | Zymfentra |
| Fresenius Kabi USA, LLC | $56.75 | 2023-2024 | Idacio |
| Amgen INC. | $55.05 | 2025 | Uplizna |
| Concordia Pharmaceuticals INC. | $52.30 | 2019 | |
| Aimmune Therapeutics, INC. | $42.39 | 2024-2025 | Zenpep |
| Alfasigma USA, INC. | $42.16 | 2020 | |
| Lucid Diagnostics INC. | $37.47 | 2023-2024 | |
| Ipsen Biopharmaceuticals, INC | $26.74 | 2024 | Bylvay |
| Romark Laboratories, Lc | $20.35 | 2019-2020 | |
| Daiichi Sankyo INC. | $19.64 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.74 | 2023 | Cyltezo |
| Merck Sharp & Dohme LLC | $18.04 | 2020 | |
| Organon LLC | $17.26 | 2024 | |
| Novo Nordisk INC | $17.02 | 2025 | Wegovy |
| Digestive Care, INC. | $14.82 | 2022 | |
| Allergan, INC. | $13.30 | 2019 | |
| Sandoz INC. | $13.18 | 2023 | Hyrimoz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Cody listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.